CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Acell Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Acell Inc
6640 Eli Whitney Drive, Suite
COLUMBIA, MD  21046  United States Fax: (410) 715-4511f:410 715-4511

This company was Merged or Acquired on 1/20/2021.
This is a Subsidiary, click here for the Parent Company

Business Summary
ACell, Inc. is a regenerative medicine company. The Company is focused on the development, manufacture and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects. Its products utilize its porcine urinary bladder matrix platform technology. It manufactures extracellular matrix (ECM), products that utilize porcine urinary bladder matrix (UBM). It markets MicroMatrix, a particulate formulation, and Cytal Wound Matrix products, in sheet formulations, for the management of acute, surgical, chronic and tunneling wounds and partial thickness burns. It also markets Gentrix Surgical Matrix products, in sheet formulations, for the reinforcement of soft tissue in certain surgical applications, such as for hernia repair.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202012/31/2019YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President Patrick A.McBrayer 69 12/31/2021 1/1/2016
Chief Financial Officer EdwardO'Brien
Senior Vice President MilesCrody
Chief Scientific Officer ThomasGilbert

General Information
Number of Employees: 400 (As of 3/31/2020)
Outstanding Shares: 22,675,510 (As of 7/17/2020)
Stock Exchange: NASD
Federal Tax Id: 043496380
Fax Number: (410) 715-4511
Email Address: info@acell.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, December 31, 2023